On average, 7 out of 10 retail investors suffer losses when trading turbo certificates. Turbo certificates are highly risky products and are not suited for long-term investment strategies.
1 - 25 of 333
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Biontech Se USD Call 110,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 1,91x
- Analysis
- Biontech Se USD Call 100,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 1,85x
- Analysis
- Biontech Se USD Call 90,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 1,79x
- Analysis
- Biontech Se USD Call 130,00 16 Oct 2026
- Goldman Sachs
- 16.10.26
- 11,35x
- Analysis
- Biontech Se USD Call 140,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,22x
- Analysis
- Biontech Se USD Call 160,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,34x
- Analysis
- Biontech Se USD Call 120,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,08x
- Analysis
- Biontech Se USD Call 88,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 1,92x
- Analysis
- Biontech Se USD Call 88,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,07x
- Analysis
- Biontech Se USD Put 120,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 1,33x
- Analysis
- Biontech Se USD Call 88,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 2,01x
- Analysis
- Biontech Se USD Call 88,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,85x
- Analysis
- Biontech Se USD Put 60,00 16 Oct 2026
- Goldman Sachs
- 16.10.26
- 6,44x
- Analysis
- Biontech Se USD Call 160,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,90x
- Analysis
- Biontech Se USD Call 160,00 19 Feb 2027
- Goldman Sachs
- 19.02.27
- 5,57x
- Analysis
- Biontech Se USD Call 140,00 19 Feb 2027
- Goldman Sachs
- 19.02.27
- 5,46x
- Analysis
- Biontech Se USD Call 120,00 19 Feb 2027
- Goldman Sachs
- 19.02.27
- 5,16x
- Analysis
- Biontech Se USD Put 50,00 19 Feb 2027
- Goldman Sachs
- 19.02.27
- 5,32x
- Analysis
- Biontech Se USD Put 110,00 15 Jan 2027
- Goldman Sachs
- 15.01.27
- 3,19x
- Analysis
- Biontech Se USD Call 80,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 1,84x
- Analysis
- Biontech Se USD Call 80,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 1,93x
- Analysis
- Biontech Se USD Call 160,00 16 Oct 2026
- Goldman Sachs
- 16.10.26
- 8,63x
- Analysis
- Biontech Se USD Call 90,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 1,95x
- Analysis
- Biontech Se USD Call 90,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 1,86x
- Analysis
- Biontech Se USD Put 80,00 19 Feb 2027
- Goldman Sachs
- 19.02.27
- 4,95x
- Analysis